New PET scan for neuroblastoma in children
Treatments studied
Part of Cancer clinical trials.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or younger
- You have or are suspected to have neuroblastoma
- Your parent or guardian agrees to the study (and if you are 8 or older and able to write, you agree too)
- You have not had too much radiation from other studies this year
- You have not taken any experimental drugs or devices in the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
This study compares two types of imaging scans to see which is better at finding neuroblastoma in children. Your child will get both a standard MIBG scan and a newer PET scan, and the results will be compared to help improve future detection.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This early-phase trial uses a special PET/CT scan to help evaluate neural crest tumors, which include conditions like neuroblastoma. It may help doctors understand how well the scan shows tumor activity to guide diagnosis and treatment planning.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
This trial uses a radioactive medicine called MIBG to target and kill neuroblastoma or related tumor cells that have not responded to standard treatments. It may help patients whose cancer has come back or is hard to treat.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.